Showing results (401-410 of 458) with videos related to

Sort By:
Pageof 46
Cancer Discovery|September 15, 2022
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk NeuroblastomaKristopher R Bosse, Anna Maria Giudice, Maria V Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology GroupAmy K Erbe, Wei Wang, Lakeesha Carmichael, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor ModelsCaitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Nature Genetics|May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastomaMario Capasso, Marcella Devoto, Cuiping Hou, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Cancer Research|January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Pageof 46